Max Healthcare Institute liquidity ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

8.49×	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.89×	0.89×	0.88×	1.37×	1.86×
0.84×	0.84×	0.82×	1.30×	1.79×
557	666	662	980	42.8
−397	−242	−221	457	898

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MAXHEALTH₹851.15

Max Healthcare Institute Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS MEDANTA DRREDDY CIPLA SUNPHARMA DIVISLAB TORNTPHARMMcap ₹82,828 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Altman Z-Score (Other Equity as RE)	—	—	—	—	8.49
Current Ratio	1.86	1.37	0.88	0.89	0.89
Quick Ratio	1.79	1.30	0.82	0.84	0.84
Cash, Equiv & ST Investments	42.8	979.8	661.6	665.8	556.7
Working Capital	897.5	457.5	-221.2	-242.2	-396.5

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.